Themis Medicare Announces 56th AGM on Sep 30, 2026, to Adopt FY26 Audited Results
Themis Medicare Limited will hold its 56th AGM on September 30, 2026, to approve FY26 financial results. FY26 consolidated revenue was ₹342.24 crore (down from ₹405.51 crore in FY25). Q4 FY26 revenue grew 6.7% YoY to ₹76.5 crore, with PAT at ₹8.9 crore.
The AGM notice is a routine corporate event. The financial results indicate a mixed performance with a year-on-year decline, which could impact investor perception. The proposed changes to Articles of Association and dividend declaration are material but standard for an AGM.
The announcement is primarily a notice for the AGM and the release of the annual report. While it includes financial results, the overall performance for FY26 shows a decline in revenue and profit compared to the previous year, which tempers a positive sentiment. The Q4 recovery offers a slightly positive note, but the year-end results are mixed.
Themis Medicare Limited has announced its 56th Annual General Meeting (AGM) scheduled for Wednesday, September 30, 2026, at 11:00 AM at its registered office in Vapi, Gujarat. The AGM will focus on transacting ordinary and special businesses, including the consideration and adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Additionally, the meeting will address the re-appointment of Mr. Rajneesh Anand as a Director and the declaration of dividend for FY 2025-26. Special business includes the ratification of remuneration for the Cost Auditor for FY 2026-27 and an amendment to the Articles of Association concerning 'Further Issue of Share Capital'. The company also released its Annual Report for FY 2025-26, which is available on its website. The financial performance for FY 2025-26 reported consolidated revenue of ₹342.24 crore, a decrease from ₹405.51 crore in FY25, with EBITDA at ₹0.39 crore and PAT at ₹1.14 crore. However, Q4 FY26 showed improvement with revenue growing 6.7% YoY to ₹76.5 crore, EBITDA to ₹3.8 crore, and PAT turning positive at ₹8.9 crore.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.